Last Updated : August 1, 2024
Details
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted: | 20-Jun-2024 |
| Stakeholder Feedback Deadline: | 27-Jun-2024 |
| Final Report Posted): | 01-Aug-2024 |
Details
Review Type: Rapid
Provisional Funding Algorithm |
|
|---|---|
| Draft Report Posted: | 20-Jun-2024 |
| Stakeholder Feedback Deadline: | 27-Jun-2024 |
| Final Report Posted: | 1- Aug-2024 |
Last Updated : August 1, 2024
Details
| Call for patient/clinician input open | June 03, 2024 |
|---|---|
| Call for patient/clinician input closed | July 26, 2024 |
| Submission received | July 15, 2024 |
| Submission accepted | July 29, 2024 |
| Review initiated | July 30, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | October 21, 2024 |
| Deadline for sponsors comments | October 30, 2024 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | November 22, 2024 |
| Expert committee meeting (initial) | December 04, 2024 |
| Draft recommendation issued to sponsor | December 16, 2024 |
| Draft recommendation posted for stakeholder feedback | January 02, 2025 |
| End of feedback period | January 16, 2025 |
| Final recommendation issued to sponsor and drug plans | January 30, 2025 |
| Final recommendation posted | February 18, 2025 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | February 13, 2025 |
| CDA-AMC review report(s) posted | - |
Last Updated : April 17, 2025
Details
Program Updates
1. Procedures for Provisional Funding Algorithms
Last Updated : May 30, 2024
Details
| Call for patient/clinician input open | May 30, 2024 |
|---|---|
| Call for patient/clinician input closed | July 19, 2024 |
| Submission received | August 13, 2024 |
| Submission accepted | August 27, 2024 |
| Review initiated | August 28, 2024 |
| Draft CADTH review report(s) provided to sponsor for comment | November 14, 2024 |
| Deadline for sponsors comments | April 10, 2025 |
| Clarification: - Submission temporarily suspended - Additional information has been received and the temporary suspension of the review has been lifted | |
| CDA-AMC review report(s) and responses to comments provided to sponsor | January 02, 2026 |
| Expert committee meeting (initial) | January 14, 2026 |
| Draft recommendation issued to sponsor | January 27, 2026 To January 29, 2026 |
| Draft recommendation posted for stakeholder feedback | February 05, 2026 |
| End of feedback period | February 20, 2026 |
Last Updated : April 11, 2025
Details
Last Updated : May 21, 2024
Details
| Call for patient/clinician input open | 14-May-24 |
|---|---|
| Call for patient/clinician input closed | 08-Jul-24 |
| Submission received | 28-Jun-24 |
| Submission accepted | 15-Jul-24 |
| Review initiated | 16-Jul-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 21-Oct-24 |
| Deadline for sponsors comments | 30-Oct-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 22-Nov-24 |
| Expert committee meeting (initial) | 04-Dec-24 |
| Draft recommendation issued to sponsor | 17-Dec-24 |
| Draft recommendation posted for stakeholder feedback | 02-Jan-25 |
| End of feedback period | 16-Jan-25 |
| Final recommendation issued to sponsor and drug plans | 29-Jan-25 |
| Final recommendation posted | 14-Feb-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 12-Feb-25 |
| CDA-AMC review report(s) posted | - |
Last Updated : April 25, 2025
Details
| Call for patient/clinician input open | 10-May-24 |
|---|---|
| Call for patient/clinician input closed | 08-Jul-24 |
| Submission received | 21-Jun-24 |
| Submission accepted | 08-Jul-24 |
| Review initiated | 09-Jul-24 |
| Draft CADTH review report(s) provided to sponsor for comment | 26-Sep-24 |
| Deadline for sponsors comments | 08-Oct-24 |
| CDA-AMC review report(s) and responses to comments provided to sponsor | 15-Nov-24 |
| Expert committee meeting (initial) | 27-Nov-24 |
| Draft recommendation issued to sponsor | 09-Dec-24 |
| Draft recommendation posted for stakeholder feedback | 19-Dec-24 |
| End of feedback period | 10-Jan-25 |
| Expert committee meeting | 26-Mar-25 |
| Final recommendation issued to sponsor and drug plans | 08-Apr-25 |
| Final recommendation posted | 28-Apr-25 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | 24-Apr-25 |
| CDA-AMC review report(s) posted | - |
Last Updated : April 28, 2025